- FTC Approves Final Order in Case Against GMR Transcription Services ( )
- Cactus Juice Marketers to Pay $3.5 Million in Refunds to Consumers for Deceptive Claims that Their Product Treats Diseases ( )
- L’Oréal Settles FTC Charges Alleging Deceptive Advertising for Anti-Aging Cosmetics ( )
- La FTC testifica ante el Subcomité de Comercio del Senado sobre los esfuerzos de la agencia para combatir las declaraciones fraudulentas y engañosas sobre productos para perder peso ( )
- FTC Testifies Before Senate Commerce Subcommittee on Agency Efforts to Combat Fraudulent and Deceptive Claims for Weight-Loss Products ( )
- Supplement Marketers Settle FTC Charges that “BrainStrong Adult†Memory Improvement Claims Are Deceptive ( )
- Company Settles FTC Charges that Head Lice Prevention Claims Were Deceptive ( )
- FTC Charges Green Coffee Bean Sellers with Deceiving Consumers through Fake News Sites and Bogus Weight Loss Claims ( )
- FTC Approves Final Consent Orders Settling Charges that Companies Deceptively Claimed Their Genetically Modified Nutritional Supplements Could Treat Diseases ( )
- FTC Staff: Missouri Should Consider Changing Physician Supervision Requirements for Advanced Practice Registered Nurses ( )
- FTC Announces Agenda, Panelists for Upcoming Seminar on Privacy Implications of Consumer Generated and Controlled Health Data ( )
- FTC Approves Final Order Settling Charges That Community Health Systems, Inc.’s Acquisition of Health Management Associates Inc. was Anticompetitive in Two Local Markets ( )
- FTC Puts Conditions on Akorn Enterprises’ Proposed Purchase of Hi-Tech Pharmacal ( )
- FTC Approves Final Consent Settling Charges that L’Occitane, Inc. Misled Consumers to Believe that Creams Could Slim Their Bodies ( )
- FTC Chairwoman Releases 2013 Annual Highlights ( )
- FTC Announces Agenda for March 20-21 Workshop Examining U.S. Health Care Competition Issues ( )
- FTC Staff Opinion: Rx Program Operated for the Benefit of Non-Profit Schools, Colleges, and Universities Appears to Fall within the NPIA Exemption to Robinson-Patman ( )
- FTC Staff Paper: State Legislators Should Carefully Evaluate Proposals to Limit Advanced Practice Registered Nurses’ Scope of Practice ( )
- FTC Approves Final Consent Settling Charges that Accretive Health Failed to Adequately Protect Consumers’ Personal Information ( )
- FTC Puts Conditions on Thermo Fisher Scientific Inc.’s Proposed Acquisition of Life Technologies Corporation ( )
- Provider of Medical Transcript Services Settles FTC Charges That It Failed to Adequately Protect Consumers’ Personal Information ( )
- FTC Puts Conditions on Endo Health Solutions’ Acquisition of Boca Life Science Holdings ( )
- Statement of FTC Chairwoman Edith Ramirez on the U.S. District Court in the District of Idaho Ruling in the Matter of the Â鶹´«Ã½ Trade Commission and the State of Idaho v. St. Luke’s Health System Ltd. and Saltzer Medical Group, P.A. ( )
- FTC Staff: Massachusetts Should Consider Removing Physician Supervision Requirements for Nurse Practitioners and Nurse Anesthetists ( )
- FTC Requires Community Health Systems, Inc. to Divest Two Hospitals as a Condition of Acquiring Rival Hospital Operator ( )
- Accretive Health Settles FTC Charges That It Failed to Adequately Protect Consumers’ Personal Information ( )
- FTC Approves Final Order Settling Charges That Mylan, Inc.’s Acquisition of Agila Specialties Global Pte. Ltd and Agila Specialties Pvt. Ltd. Was Anticompetitive ( )
- FTC Approves Final Order Settling Charges that Actavis, Inc.’s Acquisition of Warner Chilcott plc Would Be Anticompetitive in Four Current and Future Drug Markets ( )
- FTC Announces Agenda for Workshop Examining Competition Issues Surrounding Biologic and Follow-on Biologic Medicines: Biosimilars and Interchangeables ( )
- FTC Staff Submits Comment to the Commission on Dental Accreditation Regarding its Proposed Standards for Dental Therapy Education Programs ( )